LOGO
LOGO

Intraday Alerts

Amgen Inc. (AMGN) Is Losing Ground Due To Weak Q1 Revenues

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Amgen Inc. (AMGN) reported first quarter adjusted EPS of $1.96 after the bell Tuesday, up from $1.61 in the previous year. The consensus estimate was for EPS of $1.84. Revenues grew 5 percent to $4.24 billion from $4.05 billion last year. The consensus revenue estimate was $4.37 billion

Full year 2013 adjusted EPS is expected to be above the midpoint of the guidance range of $7.05 to $7.35 per share. The consensus estimate is for EPS of $7.21.

Amgen gapped open sharply lower Wednesday and is now down 6.93 at $105.83. The stock pulled back from the highs of the year yesterday and has set a 2-week low.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19